Epstein-Barr virus and the somatic hypermutation of immunoglobulin genes in Burkitt's lymphoma cells

RS Harris, Deborah Croom-Carter, Alan Rickinson, MS Neuberger

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

It has been suggested that Epstein-Barr virus (EBV) might suppress antibody maturation either by facilitating bypass of the germinal center reaction or by inhibiting hypermutation directly. However, by infecting the Burkitt's lymphoma (BL) cell line Ramos, which hypermutates constitutively and can be considered a transformed analogue of a germinal center B cell, with EBV as well as by transfecting it with selected EBV latency genes, we demonstrate that expression of EBV gene products does not lead to an inhibition of hypermutation. Moreover, we have identified two natural EBV-positive BL cell lines (ELI-BL and BL16) that hypermutate constitutively. Thus, contrary to expectations, EBV gene products do not appear to affect somatic hypermutation.
Original languageEnglish
Pages (from-to)10488-10492
Number of pages5
JournalJournal of virology
Volume75
Issue number21
DOIs
Publication statusPublished - 1 Nov 2001

Fingerprint

Dive into the research topics of 'Epstein-Barr virus and the somatic hypermutation of immunoglobulin genes in Burkitt's lymphoma cells'. Together they form a unique fingerprint.

Cite this